Indefinite Delivery Contract 75N91021D00001

Award Date 12/18/20
Last Date to Order 12/17/23
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Cancer Institute (NCI) awarded a multiple-award Indefinite Delivery Contract (IDC) with a $149,995,000 ceiling value to The Institute For Cancer Research, a non-profit organization and subsidiary of Temple University, to provide preclinical efficacy and biomarker analysis services in support of the PREVENT Cancer Preclinical Drug Development Program. This 5-year IDC contract includes three technical pools: Preclinical Efficacy and Biomarkers, Preclinical Services for Product...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at up to $74,995,000, is a multiple award with Advanced Bioscience Laboratories, Inc. (ABL) as the prime contractor. The contract supports the PREVENT Cancer Preclinical Drug Development Program, with the objective of cGMP production of vaccines and biologicals for cancer prevention. Key...
The National Institutes of Health National Cancer Institute awarded a single-award indefinite delivery contract to American Type Culture Collection to provide field and biospecimen support services. The contract has a potential value of $320 million and a period of performance from July 2022 to June 2027, with an option for additional task orders through June 2032. The contractor will perform services under five task areas to support the Division of Cancer Epidemiology and Genetics ongoing...
The Defense Health Agency awarded a single-award Indefinite Delivery Contract to Olink Proteomics Inc. with a potential value of $3.4 million. The contract provides Olink Target reagent kits to support the Walter Reed Army Institute of Research's Medical Readiness Systems Biology Branch. The Branch aims to procure the kits through May 2028 in furtherance of its medical research mission. The originating solicitation sought proposals for Olink Target reagent kits to support the Center for Military...
The National Institutes of Health National Cancer Institute awarded a single-award Indefinite Delivery Contract to Coriell Institute For Medical Research Inc. The contract supports the Division of Cancer Epidemiology and Genetics Field and Biospecimen Support Services program with a potential value of $320 million over five years. Under the contract, the contractor will provide field and biospecimen support services to assist the Division of Cancer Epidemiology and Genetics in conducting...
This is a multiple award Indefinite Delivery Contract (IDC) issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $9,950,000 and was awarded to the University of Oklahoma (OU) to provide preclinical research and development services related to cancer prevention and treatment. The task orders issued under this IDC cover a range of preclinical oncology research activities, including the evaluation of...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract, valued at $236,000.00, is part of the NCI Cancer Genome Atlas (TCGA) Program and aims to procure tissue samples and data from various cancer types for the TCGA's comprehensive genomic characterization efforts. The contract was awarded in August...
The National Institutes of Health National Cancer Institute awarded an indefinite delivery indefinite quantity multiple award contract with a potential value of $148 million to provide biomedical information management and analytic support services. Task areas under the contract include data modeling, acquisition and management; data analysis, statistical and bioinformatics analysis and tool development; and general program support. Two task orders have been issued against this contract. The...
Alchem Laboratories Corporation was awarded a single award indefinite delivery contract by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services. The contract has a potential value of $12,069,385 and a period of performance through April 10, 2028. The contract aims to procure analysis and synthesis of Good Manufacturing Practice and non-GMP bulk drugs and pharmaceutical formulations to support the National Cancer Institute's...
This indefinite delivery contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The contract, valued at $200,000, supports the NCI's Cancer Genome Atlas (TCGA) program, which aims to collect and analyze tissue samples and data from various cancer types. The initial $120,500 task order under this contract requires the...
  • 75N91021D00001
    Indefinite Delivery Contract
  • 5
    Federal Contract Awards

The National Institutes of Health National Cancer Institute awarded a single award indefinite delivery contract to Olink Proteomics AB to procure protein biomarker analysis services. Task orders issued to date against the contract include immuno-oncology, inflammation, and pediatric oncology analysis services using Olink's proprietary multiplex platforms. Services are being performed in various locations including Massachusetts, Maryland, and the District of Columbia through July 2024. Collectively the task orders are valued at approximately $700,000.

The originating solicitation sought statements of capability from Olink Proteomics AB on a sole-source basis to ensure data comparability with previous Division of Cancer Epidemiology and Genetics studies. The services to be acquired include aliquoting and testing circulating biomarkers in cancer patients to support the Division's epidemiological and genetic cancer research efforts.

Generated 1/5/24, 6:16 PM